Everest Medicines completes patient recruitment in Nefecon China open-label extension study
The primary objective of the cOLE study is to assess the efficacy and safety of extended and repeated…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
01 Aug 23
The primary objective of the cOLE study is to assess the efficacy and safety of extended and repeated…
01 Aug 23
This strategic partnership indicates a significant step forward in the cooperation between Fosun Health Capital and Medicilon, with…
01 Aug 23
Solve GNE has been actively raising funds to support a consortium of academic and private sector researchers tasked…
31 Jul 23
Reata is a global biopharmaceutical company dedicated to advancing novel therapeutics for individuals facing serious or life-threatening diseases…
31 Jul 23
The company’s first-in-human investigational new drug applications to hold a single-arm, multicenter, open-label, dose-escalation, and expansion clinical study…
31 Jul 23
The FDA approval was based on the results from a Harm Reduction’ study that showed similar levels of…
31 Jul 23
Pylclari is an 18F-PSMA positron emission tomography (PET) tracer that detects prostate-specific membrane antigen (PSMA) positive lesions with…
31 Jul 23
The acquisition is aimed at bolstering Sanofi's Consumer Healthcare (CHC) division, particularly in the Vitamin, Mineral, and Supplements…
31 Jul 23
Daewoong Pharmaceutical, "Expecting the smooth approval with the successful phase 3 clinical trial in China aiming to reach…
31 Jul 23
The US Food and Drug Administration has cleared a Numares Health test, the AXINON® LDL-p Test System, as…